Abstract:Nitric oxide (NO) is an important signaling molecule for ischemia, inflammation, angiogenesis, immune response, and cell growth and differentiation. It has recently been shown that increased production of NO within various human cancers may contribute to tumor angiogenesis, tumor growth and metastasis, and tumor-related immune suppression. NO can be produced by several NO synthases (NOS), including inducible synthase (iNOS), which is expressed during cell activation and produces NO in larger quantity and for a longer period of time than non-inducible NOSs. In this study, we examined the expression levels of iNOS mRNA and protein in prostate adenocarcinoma using a paired nonneoplastic and neoplastic primary prostate cell culture system and related prostatectomy specimens. Six pairs of neoplastic and nonneoplastic primary prostate cell cultures were established from radical prostatectomy specimens based on homogeneity of the originating tumor and the nonneoplastic tissue. Radioactive reverse transcriptase polymerase chain reaction and subsequent quantitative analysis of iNOS mRNA were performed on the cultures using β-actin as an internal control. Immunohistochemical studies with an anti-iNOS monoclonal antibody were performed on the corresponding formalin-fixed paraffin-embedded prostatectomy tissue sections. We observed marked patient-to-patient variation in “normal” levels of iNOS mRNA. However, all six neoplastic cultures showed moderately to markedly higher mRNA levels than did their paired nonneoplastic cultures. In addition, iNOS protein levels were significantly higher in paraffin-embedded prostate cancer tissue sections than in adjacent nonneoplastic tissue. Overexpression of iNOS mRNA and protein levels is present in moderately differentiated prostate adenocarcinoma and may contribute to prostate cancer angiogenesis, tumor growth, and tumor-related immunosuppression.

Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications

The role of nitric oxide synthase/ nitric oxide in infection-related cancers: Beyond antimicrobial activity

Effects of inducible nitric oxide synthase on tumorigenesis and biological characteristics in human oral cancer cell

A Potential Target for Developing Agents to Prevent or Treat Highly Aggressive Breast Cancer

Abstract IA23: "NO Target for Cancer Stem Cells"

Function of inducible nitric oxide synthase in the regulation of cervical cancer cell proliferation and the expression of vascular endothelial growth factor.

Expression of inducible nitric oxide synthase in paired neoplastic and non-neoplastic primary prostate cell cultures and prostatectomy specimen.

NO• and Pancreatic Cancer: A Complex Interaction with Therapeutic Potential.

Protein Phosphorylation in Cancer: Role of Nitric Oxide Signaling Pathway

Regulation of pleiotropic physiological roles of nitric oxide signaling

Expression of inducible nitric oxide synthase in lung carcinoma and its relation with angiogenesis

Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer

Downregulation of iNOS/NO Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer

Impact of inducible nitric oxide synthase (iNOS) expression on triple negative breast cancer outcome and activation of EGFR and ERK signaling pathways

Inducible Nitric Oxide Synthase Enhances Disease Aggressiveness in Pancreatic Cancer.

The Emerging Roles of Nitric Oxide in Ferroptosis and Pyroptosis of Tumor Cells.

Recent advances on the roles of NO in cancer and chronic inflammatory disorders

Inhibition of angiogenesis in cancer by iNOS antisense oligodeoxynucleotide

Direct Demonstration Of Negative Regulation Of Tumor Growth And Metastasis By Host-Inducible Nitric Oxide Synthase

Expression and Pathological Relevance of Inducible Nitric Oxide Synthase in Osteosarcoma of the Jaws

Nitric Oxide and Pancreatic Cancer Pathogenesis, Prevention, and Treatment